Scholars Central

Conference abstractPublished 20 Jun 2018

The role of mass spectrometry in improving the diagnosis and management of thyroid disease

Authors: Steven J Soldin

National Institutes of Health, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This talk will focus on how mass spectrometry improves both diagnosis and treatment of patients with hypothyroidism (20 million in the USA). We will discuss current problems with immunoassays for thyroid testing which frequently lead to the wrong diagnosis and poor patient management. In contrast the diagnosis of hypothyroidism is more reliable utilizing UF LCMS/ MS (ultra-filtration tandem mass spectrometry) for the measurement of FT4, FT3, TT3 and TT4. The suboptimal current role of the FDA in licensing inaccurate and unreliable immunoassay methods and the approaches of the AACC and IFCC to harmonize immunoassay platforms with reference LCMS/MS methods will be critiqued. Finally evidence of poor performance of thyroidstimulating hormone (TSH) tests in predicting thyroid disease will be discussed.

Subjects

Chemistry

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Chromatography & Separation Techniques.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Chromatography & Separation Techniques
  • SubjectChemistry
  • BylineArticles whose byline prints “Steven J Soldin”